OTC market in the Czech Republic 2015 Development forecasts for 2015-2020
  • Date of issue: October 2015
  • Delivery: Pdf file

OTC market in the Czech Republic 2015

Development forecasts for 2015-2020

This comprehensive publication delivers fresh value and growth data along with sharp analysis of the powerful trends observed on the OTC market in the Czech Republic. It provides information describing consumer preferences, legal and regulatory analysis of the effects of rules on market growth and sales totals in each main market segment.

 

The report also provides a look at the future of the market through detailed development forecasts for 2015-2020.

 

This valuable document presents…

  • In-depth coverage of key market trends and impacts, major events, regulatory structures and proposed changes and recent changes in consumer behaviour on the OTC market in the Czech Republic
  • Data and analysis of current market conditions in the pharmacy, non-pharmacy and online retail segments of the market
  • Historical data that enables readers to track recent development of the market and its segments.

 

Benefit from material that covers a wide range of key subjects…

  • Profiles of leading OTC product manufacturing companies participating on the market in the Czech Republic
  • Value and growth data representing recent and current market value, growth and sales activity in the market and its pharmacy, non-pharmacy and online channels
  • Insightful analysis of the influence of trends and the OTC preferences of Czech consumers on the market
  • Top-selling OTC medicines and dietary supplements in the Czech Republic
  • Pharmaceutical market share claimed by OTC products on this market.

 

The report offers answers to frequently asked questions…

  • What degree of growth has the OTC market in the Czech Republic experienced recently?
  • What is the saturation level for this market?
  • How do the leading companies on this market plan to achieve sales goals?
  • What are the predictions for future growth in the OTC market in the Czech Republic?
  • Which regulations have had the most impact on this market recently, and which new rules will be implemented in the near future?

 

This document was designed to support…

  • Managers of companies that manufacture OTC medicines and dietary supplements
  • Wholesale OTC distributors
  • Businesses that sell OTC products online
  • Academic, business research and consulting professionals
  • Government offices and embassies.

 

It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner. Business Analyst, Hilti Distribution, Russia
PMR provides a good service and is always open to discussion. All reports are well structured & are always on time. Member of the Managment Board, SCA Hygiene Products
We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis. Senior Trade and Investment Adviser, British Embassy in Warsaw
PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. Senior Trade and Investment Adviser, British Embassy in Warsaw
As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding. Development Manager, GVA Grimley
PMR reports are a serious contribution to the market overview picture, focusing our attention on key events in the industry as well as highlighting both general and specific market indicators. Together, these components are the base for our future forecasts of construction market development and help us to plan our sales. Market Analyst, Alpha Cement

  • Methodology
  • Executive summary
    • CE region
    • Czech Republic
  • Overview of the OTC market in the Czech Republic
    • Main trends and events on the OTC market
    • OTC market value
      • OTC market value by distribution channel
      • Share of OTC products as a proportion of the pharmaceutical market
      • Value of the OTC product market between 2008 and 2020
      • Volume of the OTC drugs market
      • Value of the dietary supplement market
      • OTC product market by therapeutic categories
    • Prices of OTC products
      • OTC drugs
    • Bestselling OTC products
      • By value
      • By volume
    • Switch from Rx to OTC
    • Advertising
      • Legal framework
      • Spending on OTC advertising
    • Key players
      • Important events pertaining to companies present on the market
  • Profiles of selected manufacturers on the OTC market in CE
    • Bayer HealthCare
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Berlin-Chemie/Menarini
      • General information
      • Financial results
      • Product portfolio
    • GlaxoSmithKline
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Krka
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Novartis/Sandoz
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Sanofi
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Teva
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Walmark
      • General information
      • Product portfolio
      • Market strategy and OTC sales in CE

Graphs

  • Value (€ bn) and change (%, y-o-y) of the OTC product market in CE, 2011-2020
  • Number of dietary supplements in the Czech Republic of which launch the National Institute of Public Health was notified and change (%), 2007-2014
  • Behaviour of professionally active Czechs in cases of flu and viral diseases, by sex (%), 2015
  • Percentage of people who have bought an OTC drug or dietary supplement while influenced by an advertisement in the Czech Republic (%), 2015
  • Proportion of overweight male population in 15 most prominent countries (%), 2030
  • Places where dietary supplements are purchased by Czechs (%), 2015
  • Reasons for buying OTC drugs and dietary supplements online among Czechs (%), February 2015
  • Reasons for not buying OTC drugs and dietary supplements online among Czechs (%), February 2015
  • Frequency of online purchases of medicines in the Czech Republic (%), 2015
  • Share of OTC drugs and dietary supplements as a proportion of the OTC pharmacy product market in the Czech Republic (%), by volume, 2007 – H2 2012-H1 2013
  • Share of OTC drugs and dietary supplements as a proportion of the OTC pharmacy product market in the Czech Republic (%), by value, 2013-2014
  • Share of OTC drugs and dietary supplements as a proportion of the Czech pharmaceutical market (%), pharmacy sales, by volume, September 2013-August 2014
  • Share of OTC drugs and dietary supplements as a proportion of the Czech pharmaceutical market (%), pharmacy sales, by value, 2014
  • Value (CZK bn) and change (%, y-o-y) of the OTC product market in the Czech Republic, 2008-2020
  • Number of packets of OTC drugs sold in the Czech Republic (million), 2009-Q1 2015
  • Value (CZK bn) and change (%, y-o-y) of the dietary supplements pharmacy market in the Czech Republic, 2009-2014
  • Average manufacturer price per packet of OTC drugs in the Czech Republic (CZK) and change (%), 2009-Q1 2015
  • Average price per packet of selected bestselling OTC drugs in the Czech Republic (CZK), 2014
  • Average price per packet of selected bestselling OTC drugs in the Czech Republic (CZK), Q1 2015
  • Number of Rx to OTC switches in the Czech Republic, 2010-2013
  • Spending on OTC products advertising in the Czech Republic (CZK m), by product category, 2010-February 2014
  • Attitudes of Czechs towards OTC drug advertising, 2015
  • Spending on pharmaceutical product internet advertising in the Czech Republic (CZK m), selected months of 2013 and 2014
  • Krka Group employee breakdown, by regions, 2014
  • Krka global revenues and net profit (€ m), 2005-H1 2015
  • Share of new products as a proportion of Krka’s total sales value (%), 2009-2014
  • Krka global revenues from OTC products (€ m) and y-o-y change (%), 2011-H1 2015
  • Share of Krka sales as a proportion of the total global market, by region (%), 2014-H1 2015
  • Krka sales in CE countries analysed (€ m), 2013-Q1 2015
  • Krka global OTC sales (%), by product groups, 2014
  • Number of Walmark employees in CE countries analysed, 2014
  • Walmark Group revenues (€ m) and change (%, y-o-y), 2011/2012-2013/2014

Tables

  • Main past events and trends, and their effect on the OTC market in the Czech Republic, 2013-2015
  • Breakdown of revenues in pharmacies located in and outside medical facilities in the Czech Republic (%), 2013
  • Attitudes towards reimbursement of alternative medicine among patients in the Czech Republic (%), 2014
  • Frequency of buying OTC drugs and dietary supplements in the Czech Republic (%), 2015
  • Frequency of buying dietary supplements in the Czech Republic (%), 2015
  • Most important factors which influence OTC purchases in the Czech Republic (%), 2015
  • Most important factors influencing purchases of dietary supplements among Czechs (%), 2015
  • Percentage of people who have noticed OTC advertisements in the Czech Republic (%), by category of media, 2015
  • Anticipated trends and events, and their effect on the OTC market in the Czech Republic, 2015-2030
  • Opinions on the expansion of sales of medicines to places other than pharmacies among Czechs (%), by sex, 2015
  • Main growth drivers of OTC market in the Czech Republic, 2014
  • OTC market in the Czech Republic, by main product categories (%), September 2013-August 2014
  • OTC market in the Czech Republic, by main product categories (CZK bn), 2012-2020
  • Selected 15 bestselling OTC drugs in the Czech Republic, wholesale sales, by value (CZK m), 2014
  • Bestselling OTC products on dry cough in the Czech Republic, by value, 2014
  • Selected 15 bestselling OTC drugs in the Czech Republic, wholesale sales, by value (CZK m), Q1 2015
  • Bestselling OTC products at a sample online pharmacy in the Czech Republic, by value, July 2015
  • Bestselling 15 OTC drugs in the Czech Republic, wholesale sales, by volume (‘000 packets), 2014
  • OTC products most recommended by pharmacists in the Czech Republic in selected product categories (%), 2014
  • Bestselling 15 OTC drugs in the Czech Republic, wholesale sales, by volume (‘000 packets), Q1 2015
  • Changes in medicinal status (Rx to OTC switch) in the Czech Republic, 2013
  • Top 10 manufacturers of OTC products in the Czech Republic, by value (CZK m), Q1 2015
  • Top 10 manufacturers of OTC products in the Czech Republic, by value (CZK m), Q2 2014-Q1 2015
  • Valosun financial results (CZK m), 2012-2014
  • General information pertaining to Bayer HealthCare, 2015
  • Sales of individual Bayer companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to Bayer product portfolio, 2015
  • General information pertaining to Berlin-Chemie/Menarini, 2015
  • Sales of individual Berlin-Chemie/Menarini companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to Berlin-Chemie/Menarini product portfolio, 2015
  • General information pertaining to GlaxoSmithKline, 2015
  • Sales of individual GSK companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to GSK product portfolio, 2015
  • General information pertaining to Krka, 2015
  • Ownership structure of Krka (%), 2015
  • Structure of Krka in CE countries analysed, 2015
  • Krka's sales of OTC products in selected CE countries (€ m), 2011-2014
  • Krka sales breakdown, by product or category of service (€ m), and change (y-o-y, %), 2014
  • Krka global sales (€ m), by region, 2012-H1 2015
  • General information pertaining to Krka product portfolio in CE countries analysed, 2015
  • Most substantial increases in sales value of Krka’s OTC products (%), H1 2015
  • General information pertaining to sales of Krka’s OTC products in the Czech Republic, 2015
  • General information pertaining to Novartis/Sandoz, 2015
  • Sales of individual Novartis/Sandoz companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to Novartis/Sandoz product portfolio, 2015
  • General information pertaining to Sanofi, 2015
  • Sales of individual Sanofi companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to Sanofi product portfolio, 2015
  • General information pertaining to Teva, 2015
  • Sales of individual Teva companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to Teva product portfolio, 2015
  • General information pertaining to Walmark, 2015
  • Ownership structure of Walmark (%), 2014
  • Structure of Walmark in CE countries analysed, 2015
  • General information pertaining to Walmark product portfolio, 2014
  • General information pertaining to sales of Walmark OTC products in the Czech Republic, 2015
  • Walmark a.s. turnover (€ m), and change (% y-o-y), 2007/2008-2012/2013